Dentsply Sirona (XRAY) Misses Q4 EPS by 3c; Offers 2022 Guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q4 EPS of $0.76, $0.03 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $1.13 billion.

GUIDANCE:

Dentsply Sirona sees FY2022 EPS of $3.05-$3.25, versus the consensus of $3.19. Dentsply Sirona sees FY2022 revenue of $4.3-4.4 billion, versus the consensus of $4.48 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• OceanaGold to acquire Ausgold in a deal valued at A$776M
• Morgan Stanley Starts Target Hospitality (TH) at Overweight